Treatment of RAAS inhibitors for hypertensive patients in the coronavirus disease 2019 pandemic from ESH/ISH/AHA statements
- Author:
Chen CHEN
1
Author Information
- Publication Type:Journal Article
- Keywords: Coronavirus disease 2019(COVID-19); Hypertension; RAAS inhibitor; SARS-CoV-2
- From: Journal of Xi'an Jiaotong University(Medical Sciences) 2020;41(5):802-806
- CountryChina
- Language:Chinese
- Abstract: Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.
